INS and type 2 diabetes mellitus: While we recognize that most studies so far have been performed in tissue from healthy or T2D individuals, many molecular features of the identified beta cell subpopulations could render them more susceptible to both immune damage (i.e., ER stress) and loss of insulin secretory capacity (i.e., proliferation) during T1D.